|
 |
| home > ebr > spring 2003 > meptides: a novel class of synthetic peptide derivatives for the potential treatment of neurodegenerative diseases |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
| A number of seemingly unrelated neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, CJD (the human form of 'mad cow' disease) and ALS (motor neurone disease) have all recently been linked to a common pathogenic process called amyloidosis. In each case a specific protein or peptide clumps together in a specific part of the brain to form toxic soluble oligomers and/or insoluble fibres, which are widely believed to cause the progressive degeneration of neurons associated with these diseases. Several academic groups and at least one biotech company are now working on a novel class of synthetic peptide derivatives ('meptides') which can inhibit and reverse this process of protein/peptide aggregation in vitro, and which have the potential to yield effective treatments or perhaps even outright cures for all these diseases. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
The 9th Annual Biological Production Forum 2010
21-23 June 2010, Frankfurt, Germany
This event focuses on both upstream and downstream processing for biological manufacturing, production and cGMP specialists. Over the course of this three day event, you will take part in a mixture of networking and conference session featuring the latest strategies and industry case studies. Included in the event this year is the opportunity to take part in a tour at Merck KGaA’s headquarters. It is a unique day which will give delegates the chance to be one of the first to tour their brand new Process Solutions and also learn about the latest advancements taking place there.
More info >> |
|
 |
News and Press Releases |
 |
BioStorage Technologies European Facility Becomes Green Powered Through Use of 100 Percent Renewable Energy
BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co, a leading Germany-based sustainable energy supplier.
More info >> |
|
 |
